Ubs Group Ag Selecta Biosciences Inc Call Options Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SELB
# of Institutions
5Shares Held
4.67MCall Options Held
0Put Options Held
0-
Nano Dimension, Inc.3.79MShares$3.18 Million25.2% of portfolio
-
Oup Management Co., LLC863KShares$724,5362.06% of portfolio
-
Ctc Capital Management, LLC11.3KShares$9,4920.03% of portfolio
-
American Portfolios Advisors Holbrook, NY7.25KShares$6,0900.0% of portfolio
-
Cutler Group LP1.7KShares$1,4280.0% of portfolio
About SELECTA BIOSCIENCES INC
- Ticker SELB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 152,712,992
- Market Cap $128M
- Description
- Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...